|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
1.000
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
1.000
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
1.000
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
1.000
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
1.000
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
1.000
|
Human Mouse |
|
|
positive regulation of sterol transport
|
GO:0032373 |
9 |
1.000
|
Human |
|
|
lipid homeostasis
|
GO:0055088 |
63 |
1.000
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
1.000
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
1.000
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
1.000
|
Human Mouse |
|
|
sterol homeostasis
|
GO:0055092 |
45 |
1.000
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
1.000
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
1.000
|
|
|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
1.000
|
Human |
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.999
|
Mouse |
|
|
response to low density lipoprotein particle
|
GO:0055098 |
2 |
0.999
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.999
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.999
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.999
|
Human Mouse |
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.999
|
Human |
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.999
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.999
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.999
|
|
|
|
positive regulation of cholesterol transport
|
GO:0032376 |
9 |
0.999
|
Human |
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.999
|
|
|
|
regulation of beta amyloid clearance
|
GO:1900221 |
1 |
0.999
|
Human |
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.998
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.998
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.998
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.998
|
Human Mouse |
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.998
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.997
|
|
|
|
intracellular cholesterol transport
|
GO:0032367 |
3 |
0.997
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.997
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.997
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.996
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.996
|
|
|
|
macromolecular complex remodeling
|
GO:0034367 |
6 |
0.996
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.996
|
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.995
|
Human |
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.995
|
Mouse |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.995
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.995
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.995
|
Human |
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.995
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.994
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.994
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.994
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.994
|
|
|
|
positive regulation of cholesterol efflux
|
GO:0010875 |
9 |
0.994
|
Human |
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.994
|
Human |
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.994
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.994
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.994
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.993
|
Human |
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.991
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.991
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.990
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.990
|
|
|
|
phospholipid catabolic process
|
GO:0009395 |
5 |
0.990
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.989
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.988
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.988
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.987
|
|
|
|
phospholipid efflux
|
GO:0033700 |
3 |
0.987
|
Human |
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.985
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.985
|
Human |
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.984
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.984
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.984
|
Human |
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.984
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.983
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.982
|
Human Mouse |
|
|
lipid storage
|
GO:0019915 |
36 |
0.982
|
Mouse |
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.981
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.981
|
Human |
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.980
|
Human |
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.979
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.979
|
|
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
5 |
0.975
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.975
|
Mouse |
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.971
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.971
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.969
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.969
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.969
|
|
|
|
response to lipoprotein particle
|
GO:0055094 |
5 |
0.967
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.965
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.963
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.962
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.958
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.956
|
|
|
|
positive regulation of phagocytosis engulfment
|
GO:0060100 |
3 |
0.955
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.955
|
|
|
|
regulation of phospholipid catabolic process
|
GO:0060696 |
2 |
0.954
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.953
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.951
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.949
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.948
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.947
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.946
|
|
|
|
stress response to metal ion
|
GO:0097501 |
3 |
0.945
|
|
|
|
phospholipid homeostasis
|
GO:0055091 |
6 |
0.945
|
|
|
|
positive regulation of reverse cholesterol transport
|
GO:1903064 |
1 |
0.945
|
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.943
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.942
|
|
|
|
sterol import
|
GO:0035376 |
2 |
0.937
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.937
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.935
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.935
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.932
|
Mouse |
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.932
|
Human |
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.928
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.927
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.923
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.922
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.920
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.919
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.916
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.914
|
Mouse |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.912
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.911
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.911
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.908
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.906
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.905
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.904
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.903
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.897
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.896
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.895
|
Human |
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.894
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.893
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.890
|
Human |
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.890
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.890
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.890
|
Human |
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.887
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.886
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.885
|
Human |
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.883
|
Human |
|
|
respiratory system development
|
GO:0060541 |
190 |
0.883
|
|
|
|
regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000163 |
1 |
0.882
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.881
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.879
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.877
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.876
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.876
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.876
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.874
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.873
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.872
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.871
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.870
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.868
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.868
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.863
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.860
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.859
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.856
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.856
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.855
|
|
|
|
negative regulation of growth of symbiont in host
|
GO:0044130 |
19 |
0.855
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.853
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.852
|
|
|
|
positive regulation of beta amyloid clearance
|
GO:1900223 |
1 |
0.846
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.843
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.839
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.838
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.838
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.837
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.836
|
|
|
|
intracellular sterol transport
|
GO:0032366 |
3 |
0.834
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.827
|
Human Mouse |
|
|
response to lithium ion
|
GO:0010226 |
10 |
0.826
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.822
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.821
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.818
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.816
|
|
|
|
negative regulation of interferon gamma mediated signaling pathway
|
GO:0060336 |
1 |
0.813
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.811
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.807
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.802
|
Mouse |
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.801
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.801
|
Human |
|
|
regulation of glutamine family amino acid metabolic process
|
GO:0000820 |
1 |
0.798
|
|
|
|
anion homeostasis
|
GO:0055081 |
16 |
0.796
|
Human |
|
|
complement activation
|
GO:0006956 |
16 |
0.794
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.791
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.790
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.788
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.784
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.784
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.783
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.783
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.783
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.781
|
Human |
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.778
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.776
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.776
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.776
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.764
|
Human |
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.759
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.759
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.758
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.757
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.752
|
|
|
|
plasma lipoprotein particle assembly
|
GO:0034377 |
6 |
0.751
|
Human |
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.749
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.747
|
Human Mouse |
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.745
|
Human |
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.744
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.743
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.741
|
Human Mouse |
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.739
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.738
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.736
|
Human |
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.736
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.735
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.727
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.727
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.726
|
Human |
|
|
glycerophospholipid catabolic process
|
GO:0046475 |
5 |
0.725
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.724
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.723
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.722
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.722
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.719
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.719
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.718
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.716
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.713
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.712
|
Human Mouse |
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.711
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.711
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.710
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.710
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.706
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.705
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.703
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.702
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.694
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.689
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.688
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.688
|
|
|
|
ethanolamine containing compound metabolic process
|
GO:0042439 |
18 |
0.687
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.686
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.684
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.683
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.681
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.680
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.679
|
Human Mouse |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.676
|
|
|
|
regulation of presynaptic membrane organization
|
GO:1901629 |
3 |
0.674
|
Human |
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.666
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.663
|
|
|
|
regulation of phospholipid efflux
|
GO:1902994 |
2 |
0.663
|
Human |
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.659
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.656
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.656
|
Human |
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.654
|
|
|
|
steroid catabolic process
|
GO:0006706 |
7 |
0.654
|
|
|
|
macrophage derived foam cell differentiation
|
GO:0010742 |
6 |
0.650
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.650
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.645
|
Human |
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.643
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.640
|
Human Mouse |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.639
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.637
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.637
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.636
|
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.636
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.636
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.627
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.623
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.622
|
Human |
|
|
negative regulation of beta amyloid formation
|
GO:1902430 |
4 |
0.620
|
Human |
|
|
negative regulation of planar cell polarity pathway involved in heart morphogenesis
|
GO:2000160 |
1 |
0.619
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.618
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.617
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.616
|
Human |
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.616
|
|
|
|
regulation of inflammatory response to antigenic stimulus
|
GO:0002861 |
21 |
0.616
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.613
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.605
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.604
|
|
|
|
lipoprotein transport
|
GO:0042953 |
7 |
0.603
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.602
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.602
|
|
|
|
high density lipoprotein particle remodeling
|
GO:0034375 |
4 |
0.601
|
Human |
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.601
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.600
|
|
|
|
regulation of hypersensitivity
|
GO:0002883 |
10 |
0.600
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.599
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.599
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.596
|
Human Mouse |
|
|
regulation of planar cell polarity pathway involved in neural tube closure
|
GO:2000167 |
1 |
0.595
|
|
|
|
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000164 |
1 |
0.594
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.592
|
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.583
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.579
|
Mouse |
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.577
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.573
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.573
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.572
|
|
|
|
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000149 |
1 |
0.570
|
|
|
|
canonical wnt signaling pathway involved in neural crest cell differentiation
|
GO:0044335 |
1 |
0.568
|
|
|
|
cellular response to increased oxygen levels
|
GO:0036295 |
1 |
0.566
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.562
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.561
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.556
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.553
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.552
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.547
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.546
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.545
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.545
|
|
|
|
low density lipoprotein particle remodeling
|
GO:0034374 |
2 |
0.543
|
|
|
|
response to vitamin
|
GO:0033273 |
6 |
0.543
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.542
|
|
|
|
regulation of cholesterol efflux
|
GO:0010874 |
13 |
0.541
|
Human |
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.540
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.540
|
|
|
|
hypersensitivity
|
GO:0002524 |
10 |
0.539
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.539
|
Human |
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.537
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.535
|
|
|
|
triglyceride catabolic process
|
GO:0019433 |
9 |
0.533
|
|
|
|
positive regulation of type ii hypersensitivity
|
GO:0002894 |
4 |
0.532
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.529
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.528
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.527
|
Human |
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.525
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.521
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.514
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.511
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.510
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.504
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.501
|
|
|
|
apoptotic cell clearance
|
GO:0043277 |
17 |
0.501
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.499
|
|
|
|
regulation of type iia hypersensitivity
|
GO:0001796 |
4 |
0.498
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.492
|
|
|
|
hindbrain radial glia guided cell migration
|
GO:0021932 |
12 |
0.490
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.489
|
Human |
|
|
positive regulation of acute inflammatory response
|
GO:0002675 |
16 |
0.489
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.488
|
Human |
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.487
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.487
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.486
|
|
|
|
positive regulation of triglyceride biosynthetic process
|
GO:0010867 |
6 |
0.484
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.484
|
|
|
|
response to chromate
|
GO:0046687 |
1 |
0.483
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.483
|
|
|
|
regulation of cholesterol storage
|
GO:0010885 |
4 |
0.480
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.480
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.479
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.478
|
|
|
|
regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000165 |
1 |
0.477
|
|
|
|
response to interleukin 1
|
GO:0070555 |
11 |
0.473
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.473
|
Human |
|
|
positive regulation of keratinocyte differentiation
|
GO:0045618 |
3 |
0.472
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.467
|
Human |
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.467
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.466
|
Human Mouse |
|
|
negative regulation of cellular amide metabolic process
|
GO:0034249 |
4 |
0.461
|
Human |
|
|
positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000060 |
8 |
0.460
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.453
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.452
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.448
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.448
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.446
|
|
|
|
urea metabolic process
|
GO:0019627 |
3 |
0.445
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.443
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.442
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.441
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.440
|
Human |
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.439
|
Human |
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.436
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.434
|
Human Mouse |
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.432
|
|
|
|
negative regulation of endocytosis
|
GO:0045806 |
12 |
0.432
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.428
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.428
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.426
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.426
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.426
|
Human Mouse |
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.423
|
|
|
|
nitrogen cycle metabolic process
|
GO:0071941 |
3 |
0.422
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.420
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.418
|
Human |
|
|
skeletal system development
|
GO:0001501 |
356 |
0.416
|
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.415
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.414
|
|
|
|
t cell migration
|
GO:0072678 |
19 |
0.411
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.410
|
|
|
|
regulation of urea metabolic process
|
GO:0034255 |
1 |
0.410
|
|
|
|
cellular zinc ion homeostasis
|
GO:0006882 |
9 |
0.409
|
|
|
|
growth of symbiont in host
|
GO:0044117 |
23 |
0.408
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.408
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.408
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.406
|
|
|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.405
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.403
|
Human |
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
23 |
0.401
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.401
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.400
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.399
|
|
|
|
positive regulation of triglyceride lipase activity
|
GO:0061365 |
3 |
0.399
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.398
|
Human Mouse |
|
|
negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:2000151 |
1 |
0.398
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.397
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.394
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.393
|
Human |
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.393
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.390
|
Human |
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.385
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.382
|
Mouse |
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.379
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.378
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.377
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.375
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.374
|
Human |
|
|
protein secretion
|
GO:0009306 |
111 |
0.374
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.372
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.372
|
Human |
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.372
|
|
|
|
positive regulation of b cell mediated immunity
|
GO:0002714 |
26 |
0.372
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.369
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.368
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.368
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.365
|
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.363
|
|
|
|
urea cycle
|
GO:0000050 |
2 |
0.362
|
|
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
3 |
0.362
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.361
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.360
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
25 |
0.360
|
|
|
|
response to fluid shear stress
|
GO:0034405 |
7 |
0.360
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.358
|
Human |
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.358
|
Human |
|
|
myelination
|
GO:0042552 |
74 |
0.357
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.357
|
Human |
|
|
regulation of type ii hypersensitivity
|
GO:0002892 |
4 |
0.356
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.354
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.353
|
|
|
|
positive regulation of hypersensitivity
|
GO:0002885 |
7 |
0.352
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.352
|
|
|
|
regulation of reverse cholesterol transport
|
GO:1903062 |
1 |
0.351
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.351
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.347
|
Mouse |
|
|
peptide secretion
|
GO:0002790 |
114 |
0.346
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.346
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.342
|
|
|
|
positive regulation of acute inflammatory response to antigenic stimulus
|
GO:0002866 |
7 |
0.341
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.340
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.337
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.336
|
|
|
|
canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development
|
GO:0061310 |
1 |
0.336
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.335
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.334
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.334
|
Human |
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.333
|
|
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.331
|
|
|
|
regulation of cholesterol homeostasis
|
GO:2000188 |
9 |
0.330
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.328
|
Human |
|
|
glutamate metabolic process
|
GO:0006536 |
9 |
0.327
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.325
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.325
|
|
|
|
tyrosine phosphorylation of stat1 protein
|
GO:0042508 |
3 |
0.320
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.319
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.313
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.313
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.313
|
|